Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyâ
2026-03-17RXRX144Taylor Ben R plan to sell securities of RECURSION PHARMACEUTICALS, INC. under Form 144MEDIUM
Taylor Ben R filed Form 144 to notify SEC of plan to sell 7956 units of RECURSION PHARMACEUTICALS, INC. securities around 2026-03-17, with aggregate market value of $26,970.84. The total outstanding units is 521950663.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in p...
Small CapBiotechnology
2026-03-17ROIV144Venker Eric plan to sell securities of Roivant Sciences Ltd. under Form 144MEDIUM
Venker Eric filed Form 144 to notify SEC of plan to sell 200000 units of Roivant Sciences Ltd. securities around 2026-03-17, with aggregate market value of $5,648,836.44. The total outstanding units is 715701137.0. The amount planned to be sold represents 0.03% of total outstanding units; Recent transactions in past 3 ...
Large CapBiotechnology
2026-03-17MCRB144TERESA L YOUNG plan to sell securities of SERES THERAPEUTICS, INC. under Form 144MEDIUM
TERESA L YOUNG filed Form 144 to notify SEC of plan to sell 8553 units of SERES THERAPEUTICS, INC. securities around 2026-03-17, with aggregate market value of $77,966.58. The total outstanding units is 9586298.0. The amount planned to be sold represents 0.09% of total outstanding units; Recent transactions in past 3 m...
Micro CapBiotechnology
2026-03-17TARS144Whitfield Dianne C. plan to sell securities of Tarsus Pharmaceuticals, Inc. under Form 144MEDIUM
Whitfield Dianne C. filed Form 144 to notify SEC of plan to sell 4029 units of Tarsus Pharmaceuticals, Inc. securities around 2026-03-17, with aggregate market value of $279,671.82. The total outstanding units is 42557492.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions ...
Mid CapBiotechnology
2026-03-17TARS144Wahl Bryan plan to sell securities of Tarsus Pharmaceuticals, Inc. under Form 144MEDIUM
Wahl Bryan filed Form 144 to notify SEC of plan to sell 4084 units of Tarsus Pharmaceuticals, Inc. securities around 2026-03-17, with aggregate market value of $283,489.63. The total outstanding units is 42557492.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Mid CapBiotechnology
2026-03-16ABEO144Vazzano Joseph Walter plan to sell securities of ABEONA THERAPEUTICS INC. under Form 144MEDIUM
Vazzano Joseph Walter filed Form 144 to notify SEC of plan to sell 785 units of ABEONA THERAPEUTICS INC. securities around 2026-03-16, with aggregate market value of $3,737.00. The total outstanding units is 51191361.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in pa...
Micro CapBiotechnology